What percentage of NEU's SP is attributable to the possibility that trofinetide and/or NNZ-2591 will have a positive impact on those suffering from autism?
Zero?
- Forums
- ASX - By Stock
- NEU
- Ann: Q2 2020 Activity Report and Cash Flow Report
NEU
neuren pharmaceuticals limited
Add to My Watchlist
1.56%
!
$12.90

Ann: Q2 2020 Activity Report and Cash Flow Report, page-3
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$12.90 |
Change
-0.205(1.56%) |
Mkt cap ! $1.597B |
Open | High | Low | Value | Volume |
$13.20 | $13.36 | $12.82 | $3.396M | 259.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
25 | 1236 | $12.89 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$12.90 | 302 | 15 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
22 | 617 | 12.860 |
5 | 839 | 12.850 |
8 | 2279 | 12.840 |
7 | 1625 | 12.830 |
8 | 1619 | 12.820 |
Price($) | Vol. | No. |
---|---|---|
12.880 | 893 | 8 |
12.890 | 574 | 6 |
12.900 | 1253 | 6 |
12.910 | 1237 | 5 |
12.920 | 1416 | 5 |
Last trade - 15.19pm 16/06/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |